within Pharmacolibrary.Drugs.ATC.J;

model J01MB01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.6,
    Cl             = 7 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 300 / 1000000,
    adminCount     = 1,
    Vd             = 0.09,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.013333333333333334,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Rosoxacin is a first-generation quinolone antibiotic formerly used for the treatment of uncomplicated urinary tract infections and gonorrhea. It is no longer widely used or approved in most countries due to the development of safer and more effective antibiotics.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for healthy adult individuals based on class data and sparse historical reports. No modern referenced PK study available.</p><h4>References</h4><ol><li><p>Kullberg, MP, et al., &amp; Edelson, J (1979). High-performance liquid chromatographic analysis of rosoxacin and its N-oxide metabolite in plasma and urine. <i>Journal of chromatography</i> 173(1) 155–163. DOI:<a href=&quot;https://doi.org/10.1016/s0021-9673(01)80455-6&quot;>10.1016/s0021-9673(01)80455-6</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/546869/&quot;>https://pubmed.ncbi.nlm.nih.gov/546869</a></p></li><li><p>Jensen, KM, &amp; Madsen, PO (1983). Distribution of quinoline carboxylic acid derivatives in the dog prostate. <i>The Prostate</i> 4(4) 407–414. DOI:<a href=&quot;https://doi.org/10.1002/pros.2990040411&quot;>10.1002/pros.2990040411</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6223287/&quot;>https://pubmed.ncbi.nlm.nih.gov/6223287</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end J01MB01;
